Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1094 |
---|---|
Product Name | Anti-Human TNFA Recombinant Antibody(Infliximab) |
Molecular Name | Infliximab |
Alias | Anti-TNFA Recombinant Antibody, Research Grade Infliximab |
CAS Number | 170277-31-3 |
Molecular Weight | 149 kDa |
Target | TNFA[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, WB |
Buffer | PBS, pH7.5 |
Background | Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |